Post-IPO Equity Biotechnology Companies

ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.

Celadon's objective is to improve the quality of life for the most vulnerable people by producing cannabis-based medications.

Context Therapeutics is a clinical-stage biopharmaceutical company.

FluroTech LTD advances the science of fluorescence spectroscopy to solve unique issues and bring new, low-cost solutions to market.

Tryp Identifying and developing clinical-stage compounds for orphan diseases and other diseases with high unmet medical needs.

TFF Pharmaceuticals is a clinical-stage biopharmaceutical company that develops drug products.

Vincerx Pharma is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology.

Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.

Rallybio is an biotechnological research and development services intended to transform the lives of patients with a devastating disease.

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

Gritstone bio is a biotechnology company that develops immunotherapies for cancer and infectious diseases.

Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.

Applied UV focuses on the development and acquisition of technologies on infection prevention in healthcare, hospitality, and residential.

Nkarta Therapeutics is a developer of cell engineering platform created to build the next generation of cell therapies.

Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke.

Unicycive Therapeutics provides development programs that focus on treating kidney diseases with unmet medical needs.

ASLAN Pharmaceuticals is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies.

Scorpius Biomanufacturing is a CDMO specializing in mammalian, microbial, and cell therapies for biologics development and manufacturing.

SDS Optic specializes in pre-assembling of hermetic and standard photoelectronics components.

Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.

Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.

Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.

Autolus is a biopharmaceutical company focused on T-cell programming and manufacturing technology.

BioSenic is a forward-thinking firm that aims to address critical unmet medical needs.

NexImmune is a biopharmaceutical company developing novel immuno-therapeutics based on the proprietary artificial immune technology.